Home » Posts tagged 'tomography'
Tag Archives: tomography
Feedback PLC – Collaboration with the University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Feedback plc (FDBK), the medical imaging software company, is pleased to announce that it has signed a research agreement with The University of Texas MD Anderson Cancer Center in Houston, Texas, USA, to investigate the potential future clinical application of Feedback’s TexRAD texture analysis software on computed tomography (CT) image data of patients with kidney and adrenal cancer. This will be a retrospective study and the results will not be used to influence or guide the treatment regime for existing patients.
The research collaboration will be led by Prof. Haesun Choi (Professor, Department of Diagnostic Radiology, MD Anderson Cancer Center). Prof. Choi is a world leading imaging expert and is renowned for developing the CT based “Choi criteria” for assessing response to anti-vascular therapy extensively used around the world in clinical, research and pharmaceutical drug trials.
Prof. Haesun Choi commented: “Limitations of the size-based traditional response evaluation criteria in solid tumor have been well recognized, particularly, in those treated with the new molecularly targeted agents. More reliable user-friendly biomarkers that can reflect the tumor response and that can be used in risk-stratification are needed. The tumors are known to be heterogeneous in their phenotypes and genotypes. Analyzing the tumor heterogeneity on CT images may provide insights of tumors that may be useful in evaluating the tumor response. MD Anderson Cancer Center currently is exploring of the potential value of this new mean in kidney cancers.”
Dr. Balaji Ganeshan, Chief Scientist & New Business Officer of the Company’s subsidiaries TexRAD Ltd & Cambridge Computed Imaging Ltd commented: “Prof. Haesun Choi is one of the top and highly recognized imaging experts based at the very prestigious MD Anderson Cancer Center. For the last 25 years MD Anderson Cancer Center has consistently ranked as one of the USA’s top two cancer centres receiving over 120,000 people last year for care, services and clinical trial. We are delighted that she will be leading the large comprehensive patient population study (around 400 patients with kidney and adrenal cancers) on CT to strengthen the evidence base of TexRAD as the leading tumour texture heterogeneity analysis software. The investigation in kidney and adrenal cancer patient risk-stratification and treatment response evaluation, will potentially lead to the established use of TexRAD in pharmaceutical drug trials and clinical management. Working with MD Anderson Cancer Center will significantly enhance our TexRAD research collaborator base and credibility with the addition of this key site in the USA.”
For further information contact:
Tel: 01954 718072
Simon Barrell / Trevor Brown / Tom Charlton
Sanlam Securities UK (Nominated Adviser and Joint Broker)
Tel: 020 7628 2200
Simon Clements / Virginia Bull
Peterhouse Corporate Finance Ltd (Joint Broker)
Tel: 020 7469 0936
Lucy Williams / Duncan Vasey
Feedback plc is pleased to announce that it is undertaking a study cheap mlb jerseys using wholesale nfl jerseys its TexRAD research product with the Diagnostic Radiology department at the Princess Alexandra Hospital in Brisbane, Australia to assess the potential for clinical workflow integration for TexRAD quantitative computed tomography specifically focused on Минска non-small cell lung cancer.
The study will be led by Prof. Ken Miles (Senior Medical Officer in the Diagnostic Radiology department of PAH). Prof. Miles is also a Professorial Research Associate in the Institute of Flipster Nuclear Medicine, University College London, UK. Prof. Miles has an international reputation in functional imaging of tumours, ranging from the development of new techniques through St, to demonstrating cost-effectiveness. For example he has been one of the pioneers of CT perfusion (blood-flow) and CT texture (heterogeneity) analysis technologies.
Prof. Ken Miles commented: “TexRAD as research software has been used to Normal investigate lung cancer on CT where it has been shown to be associated with underlying tumour biology and has the Graphics potential to be an independent prognostic marker. Preliminary studies TexRAD have also demonstrated potential clinical applications for TexRAD analysis to assist treatment decisions and optimise lung cancer patient management in a cost-effective manner. We hope this study will demonstrate that TexRAD could be incorporated into the routine radiological workflow.”
Dr. Balaji Ganeshan, Chief Scientist & New Business Officer of the Company’s subsidiaries TexRAD Ltd & Cambridge Computed Imaging Ltd commented: “Prof. Ken Miles is one of the top functional imaging academics, dual wholesale nfl jerseys trained in radiology and nuclear medicine and we are delighted that he will be leading the very first landmark study in evaluating potential clinical implementation with our TexRAD software focused on lung cancer. Working with Princess Alexandra Hospital in Brisbane will Barclays enhance our TexRAD research cheap nba jerseys collaborator base with the addition of a key site in this new geographical region.”